Cresco Labs(CNSX) CL

Market CapCA$420.75M

Since IPO (2018)-83%

5 Year-91%

1 Year-32%

1 Month+13%

CA$1.13

+4.63%

+0.05Today

Cresco Labs last closing stock price
Metric	Price	Date
Last close	CAD 1.13	2026-08-21

Cresco Labs stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+2.73%	CAD 1.10	2026-08-14
1 month	+13%	CAD 1.00	2026-07-22
3 month	-5.04%	CAD 1.19	2026-05-22
Year to date	-31.93%	CAD 1.66	2025-12-31
1 year	-32.34%	CAD 1.67	2025-08-21
3 year	-21.53%	CAD 1.44	2023-08-22
5 year	-90.9%	CAD 12.42	2021-08-20
Since inception	-82.75%	CAD 6.55	2018-12-03

Cresco Labs Financials at a Glance

Market Cap

CA$420.75M

Revenue (TTM)

$648.65M

Net Income (TTM)

-$100.70M

EPS (TTM)

-CA$0.41

P/E Ratio

-2.79

Dividend

CA$0.00

Beta (Volatility)

1.26 (Average)

Dividend

CA$0.00

Beta (Volatility)

1.26 (Average)

Price

CA$1.13

Volume

96,558

Open

CA$1.11

Price

CA$1.13

Volume

96,558

Open

CA$1.11

Previous Close

CA$1.08

Daily Range

CA$1.07 - CA$1.13

52-Week Range

CA$0.89 - CA$3.12

Estimated Earnings Date

Nov 5, 2026

Dividend

CA$0.00

Beta (Volatility)

1.26 (Average)

Price

CA$1.13

Volume

96,558

Open

CA$1.11

Previous Close

CA$1.08

Daily Range

CA$1.07 - CA$1.13

52-Week Range

CA$0.89 - CA$3.12

Estimated Earnings Date

Nov 5, 2026

CL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cresco Labs

Cresco Labs Inc. is a leading company in the cannabis industry, focusing on cultivating medical-grade cannabis and manufacturing related products. The company is dedicated to regulatory compliance and developing condition-specific strains for both medical and adult-use consumers.

Products and Services

Cultivation of medical-grade cannabis
Manufacturing of cannabis-derived products
Distribution to medical and adult-use consumers

Growth Outlook

Revenue increased to $173.34 million in Q2 2026
Gross profit margin improved to 50.2% in Q2 2026
Operating income reached $13.36 million in Q2 2026

Financial Highlights

Trailing twelve months revenue of $628.8 million
Net income of $16.8 million reported in Q2 2026
Current ratio of 1.78 indicates strong liquidity

Cresco Labs Inc. operates in the rapidly growing cannabis sector, which has seen significant expansion in recent years. The company's focus on medical-grade products positions it well to capitalize on increasing demand. Recent financial performance shows a positive trend, with a notable increase in revenue and gross profit margins, reflecting effective operational strategies. The current ratio suggests that the company maintains a solid liquidity position, which is crucial for navigating the evolving market landscape. Overall, Cresco Labs Inc. presents an intriguing opportunity for investors interested in the cannabis industry.

AI Generated • Aug 19, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

2,900

CEO

Charles Bachtell

Website

www.crescolabs.com

Headquarters

Chicago, IL 60661, US

CL Financials

Key Financial Metrics (TTM)

Gross Margin

48.41%

Operating Margin

9.83%

Net Income Margin

-15.88%

Return on Equity

-28.27%

Return on Capital

8.34%

Return on Assets

-8.19%

Earnings Yield

-35.84%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$420.75M

Shares Outstanding

372.35M

Volume

96.56K

Avg. Volume

101.47K

Financials (TTM)

Gross Profit

$308.40M

Operating Income

$75.17M

EBITDA

$113.75M

Operating Cash Flow

$43.93M

Capital Expenditure

-$35.20M

Free Cash Flow

$8.73M

Cash & ST Invst.

$32.87M

Total Debt

$592.02M

Cresco Labs Performance Analysis

Cresco Labs annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 1,097,047,199	6.5%
2023	2023-12-31	USD 1,040,453,436	-5.2%
2024	2024-12-31	USD 992,322,083	-4.6%
2025	2025-12-31	USD 916,407,514	-7.7%

Cresco Labs sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	0.8%
Q4	2025-12-31	-2.0%
Q1	2026-03-31	-7.9%
Q2	2026-06-30	16.5%

Cresco Labs annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.93	-39.4%
2023	2023-12-31	USD -0.73	-21.0%
2024	2024-12-31	USD -0.30	-59.7%
2025	2025-12-31	USD -0.53	80.6%

Cresco Labs sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-2.8%
Q4	2025-12-31	-448.5%
Q1	2026-03-31	86.4%
Q2	2026-06-30	213.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$173.34M

+5.9%

Gross Profit

$86.95M

+4.4%

Gross Margin

50.16%

N/A

Market Cap

CA$420.75M

N/A

Market Cap/Employee

CA$145.09K

N/A

Employees

2,900

N/A

Net Income

$16.80M

+202.8%

EBITDA

$26.54M

-13.5%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$32.87M

-77.6%

Total Debt

$592.02M

-6.2%

Accounts Receivable

$39.88M

+1.0%

Inventory

$111.17M

+24.7%

Long Term Debt

$566.24M

-6.8%

Short Term Debt

$25.78M

+10.0%

Return on Assets

-8.19%

N/A

Return on Invested Capital

5.69%

N/A

Free Cash Flow

$4.45M

+199.6%

Operating Cash Flow

$15.43M

+74.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CPH.TOCipher Pharmaceuticals Inc.

CPH.TOCipher Pharmaceuticals Inc.CA$14.10-1.54%

ACB.TOAurora Cannabis Inc.

ACB.TOAurora Cannabis Inc.CA$5.41+3.05%

VHI.TOVitalhub Corp.

VHI.TOVitalhub Corp.CA$8.07+2.09%

TSND.TOTerrAscend Corp.

TSND.TOTerrAscend Corp.CA$0.87+3.57%

WEED.TOCanopy Growth Corporation

WEED.TOCanopy Growth CorporationCA$1.46+0.69%

OGI.TOOrganigram Global Inc.

OGI.TOOrganigram Global Inc.CA$1.71+3.01%

GUD.TOKnight Therapeutics Inc.

GUD.TOKnight Therapeutics Inc.CA$9.66+0.31%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.77+0.10%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$43.68+0.06%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.41+0.06%

MARAMara Holdings

MARAMara Holdings$11.26+0.01%

NVDANvidia

NVDANvidia$214.72-0.01%

INTCIntel

INTCIntel$90.07-0.02%

MRNAModerna

MRNAModerna$145.13+0.09%

Questions About CL

What is the current price of Cresco Labs?

Cresco Labs is trading at CA$1.13 per share.

What is the 52-week range for Cresco Labs?

Over the past 52 weeks, Cresco Labs has traded between CA$0.89 and CA$3.12.

How much debt does Cresco Labs have?

As of the most recent reporting period, Cresco Labs reported total debt of $839.93M.

How much cash does Cresco Labs have on hand?

Cresco Labs reported $90.96M in cash and cash equivalents in its most recent financial results.

What is Cresco Labs’s dividend yield?

Cresco Labs does not currently have a dividend yield.

Cresco Labs(CNSX) CL

Cresco Labs Financials at a Glance

CL News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cresco Labs

CL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cresco Labs Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CL

What is the current price of Cresco Labs?

What is the 52-week range for Cresco Labs?

How much debt does Cresco Labs have?

How much cash does Cresco Labs have on hand?

What is Cresco Labs’s dividend yield?

Premium Investing Services